Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print


Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com


Buscar en contenido


sábado, 25 de febrero de 2017


EMOttawa - February 23, 2017 - By Noam Katz
"The use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has become a topic of considerable interest as of late, primarily to treat non-compressible truncal hemorrhage (NCTH). However, it is beginning to expand into other causes of non-compressible bleeding...
Summing it all up
REBOA has proven itself to likely be a true player in the management of NCTH in trauma with the potential for use in other pathologies requiring urgent hemorrhage control. It has shown itself to seemingly be at least as effective as resuscitative thoracotomy (perhaps better?) and certainly creates much less of a secondary iatrogenic injury. Burgeoning advances in catheter technology, increasing utilization in major international trauma centres and considerations of altering balloon inflation characteristics all lend themselves to an exciting time in the treatment of one of the most lethal problems we face as physicians, with the real potential to vastly improve patient outcomes."